{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:08:05Z","timestamp":1787069285344,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bioorg.2025.108126","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T16:15:44Z","timestamp":1736007344000},"page":"108126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5751-5679","authenticated-orcid":false,"given":"Vijay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1899-4456","authenticated-orcid":false,"given":"Kailash","family":"Jangid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayapriya","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Ranjan","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder Singh","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-9438","authenticated-orcid":false,"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108126_b0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s004060050027","article-title":"The case described by Alois Alzheimer in 1911","volume":"248","author":"M\u00f6ller","year":"1998","journal-title":"Eur. Arch. Psychiatry. Clin. Neurosci ."},{"key":"10.1016\/j.bioorg.2025.108126_b0010","doi-asserted-by":"crossref","unstructured":"Alzheimer's disease facts and figures, Alzheimers. Dement., 18 (2022) 700-789.","DOI":"10.1002\/alz.12638"},{"key":"10.1016\/j.bioorg.2025.108126_b0015","doi-asserted-by":"crossref","unstructured":"R.A. Stelzmann, H. Norman Schnitzlein, F. Reed Murtagh, An english translation of Alzheimer's 1907 paper, \u201c\u00fcber eine eigenartige erkankung der hirnrinde\u201d, Clin Anat., 8 (1995) 429-431.","DOI":"10.1002\/ca.980080612"},{"key":"10.1016\/j.bioorg.2025.108126_b0020","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of multifunctional molecules as potential therapeutic candidates for Alzheimer\u2019s disease, parkinson\u2019s disease, and amyotrophic lateral sclerosis in the last decade","volume":"119","author":"Savelieff","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108126_b0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fnagi.2019.00317","article-title":"Dreaming of a new world where Alzheimer\u2019s is A treatable disorder","volume":"11","author":"Catania","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bioorg.2025.108126_b0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.psc.2022.07.003","article-title":"Pathophysiology of Alzheimer\u2019s disease","volume":"45","author":"Yarns","year":"2022","journal-title":"Psychiatr. Clin. n. Am."},{"key":"10.1016\/j.bioorg.2025.108126_b0035","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer\u2019s cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2025.108126_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bioorg.2025.108126_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","article-title":"Synapse pathology in Alzheimer\u2019s disease","volume":"139","author":"Griffiths","year":"2023","journal-title":"Semin. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108126_b0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/revneuro-2022-0087","article-title":"Dysfunctional microglia and tau pathology in Alzheimer\u2019s disease","volume":"34","author":"Ayyubova","year":"2022","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2025.108126_b0055","doi-asserted-by":"crossref","unstructured":"C. Picard, N. Nilsson, A. Labont\u00e9, D. Auld, P. Rosa-Neto, t.A.s.D.N. Initiative, N.J. Ashton, H. Zetterberg, K. Blennow, J.C.B. Breitner, S. Villeneuve, J. Poirier, f.t.P.-A.r. group, Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease, Alzheimers. Dement., 18 (2022) 875-887.","DOI":"10.1002\/alz.12442"},{"key":"10.1016\/j.bioorg.2025.108126_b0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/1568026619666190128125912","article-title":"Target Enzyme in Alzheimer\u2019s disease: Acetylcholinesterase inhibitors","volume":"19","author":"Saxena","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108126_b0065","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12668-016-0375-x","article-title":"Role of acetylcholinesterase in \u03b2-amyloid aggregation studied by accelerated molecular dynamics","volume":"7","author":"Lushchekina","year":"2017","journal-title":"BioNanoScience"},{"key":"10.1016\/j.bioorg.2025.108126_b0070","series-title":"Alzheimer\u2019s Disease: Cellular and Molecular Aspects of Amyloid \u0392,","first-page":"299","article-title":"Acetylcholinesterase interaction with Alzheimer amyloid \u03b2,","author":"Inestrosa","year":"2005"},{"key":"10.1016\/j.bioorg.2025.108126_b0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cbi.2016.04.009","article-title":"AChE and the amyloid precursor protein (APP) \u2013 Cross-talk in Alzheimer's disease","volume":"259","author":"Nalivaeva","year":"2016","journal-title":"Chem.-Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.108126_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101819","article-title":"Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer\u2019s disease: relevance for precision medicine in neurodegenerative diseases","volume":"84","author":"Lista","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108126_b0085","unstructured":"J. O'Sullivan, K. Tipton, M. Youdim, Monoamine oxidase (MAO): functions in the central nervous system, 2004."},{"key":"10.1016\/j.bioorg.2025.108126_b0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/BMC.2011.030","article-title":"Structures and mechanism of the monoamine oxidase family","volume":"2","author":"Gaweska","year":"2011","journal-title":"Biomol. Concepts."},{"key":"10.1016\/j.bioorg.2025.108126_b0095","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of Multifunctional Molecules as potential therapeutic candidates for Alzheimer\u2019s disease, Parkinson\u2019s disease, and Amyotrophic Lateral Sclerosis in the last decade","volume":"119","author":"Masha","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108126_b0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-017-0279-1","article-title":"Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with \u03b3-secretase and regulates neuronal amyloid \u03b2-peptide levels","volume":"9","author":"Weiss","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bioorg.2025.108126_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0161-813X(03)00085-8","article-title":"Progress in Monoamine oxidase (MAO) research in relation to genetic engineering","volume":"25","author":"Nagatsu","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bioorg.2025.108126_b0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1389450117666151209123402","article-title":"A perspective on monoamine oxidase enzyme as drug target: Challenges and opportunities","volume":"18","author":"Kumar","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioorg.2025.108126_b0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2016.00340","article-title":"Inhibitors of MAO-A and MAO-B in psychiatry and neurology","volume":"7","author":"Finberg","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108126_b0120","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/ijms21207660","article-title":"Cpper toxicity links to pathogenesis of Alzheimer\u2019s Disease and Therapeutics Approaches","volume":"21","author":"Ejaz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108126_b0125","article-title":"Alzheimer's disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.bioorg.2025.108126_b0130","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/med.21699","article-title":"From combinations to multitarget-directed ligands: A continuum in Alzheimer's disease polypharmacology","volume":"41","author":"Albertini","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108126_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116742","article-title":"Advancements in the development of multi-target directed ligands for the treatment of Alzheimer\u2019s disease","volume":"61","author":"Kumar","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108126_b0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/acschemneuro.8b00220","article-title":"4,6-Diphenylpyrimidine derivatives as dual inhibitors of monoamine oxidase and acetylcholinesterase for the treatment of Alzheimer\u2019s disease","volume":"10","author":"Kumar","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2025.108126_b0145","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/cmdc.201700589","article-title":"Synthesis, biological evaluation and molecular modeling studies of propargyl-containing 2,4,6-trisubstituted pyrimidine derivatives as potential anti-Parkinson agents","volume":"13","author":"Kumar","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108126_b0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejmech.2019.05.039","article-title":"Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase","volume":"177","author":"Kumar","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108126_b0155","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1002\/slct.202002425","article-title":"Design, synthesis and evaluation of o-pentyne substituted diphenylpyrimidines as monoamine oxidase and acetylcholinesterase inhibitors","volume":"5","author":"Kumar","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.108126_b0160","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1021\/acschemneuro.2c00132","article-title":"Design, synthesis, and pharmacological evaluation of n-propargylated diphenylpyrimidines as multitarget directed ligands for the treatment of Alzheimer\u2019s disease","volume":"13","author":"Kumar","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2025.108126_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113949","article-title":"Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review","volume":"227","author":"Haghighijoo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108126_b0170","doi-asserted-by":"crossref","first-page":"22360","DOI":"10.1039\/C7RA02889J","article-title":"Application of quinazoline and pyrido[3,2-d]pyrimidine templates to design multi-targeting agents in Alzheimer's disease","volume":"7","author":"Mohamed","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108126_b0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bioorg.2017.07.014","article-title":"Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer\u2019s disease","volume":"74","author":"Haghighijoo","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108126_b0180","doi-asserted-by":"crossref","unstructured":"M. Wang, H-L Qin, J. Leng, Ameeduzzafar, M. W. Amjad, M. A. G. Raja, M. A. Hussain, S. N. A. Bukhari, Synthesis and biological evaluation of new tetramethylpyrazine-based chalcone derivatives as potential anti-Alzheimer agents. Chem Biol Drug Des., 92(2018) 1859-1866.","DOI":"10.1111\/cbdd.13355"},{"key":"10.1016\/j.bioorg.2025.108126_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2017.1304905","article-title":"ThT 101: a primer on the use of thioflavin T to investigate amyloid formation","volume":"24","author":"Gade Malmos","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.bioorg.2025.108126_b0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2017.219","article-title":"Mechanistic enzymology in drug discovery: a fresh perspective","volume":"17","author":"Holdgate","year":"2018","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.bioorg.2025.108126_b0195","series-title":"Comprehensive Enzyme Kinetics","first-page":"73","author":"Inhibition","year":"2003"},{"key":"10.1016\/j.bioorg.2025.108126_b0200","series-title":"Atomistic Approaches in Modern Biology: from Quantum Chemistry to Molecular Simulations","first-page":"173","article-title":"QM\/MM Methods for Biological Systems","author":"Senn","year":"2007"},{"key":"10.1016\/j.bioorg.2025.108126_b0205","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1080\/00268976.2017.1333644","article-title":"Thirty years of density functional theory in computational chemistry: an overview and extensive assessment of 200 density functionals","volume":"115","author":"Mardirossian","year":"2017","journal-title":"Mol. Phys."},{"key":"10.1016\/j.bioorg.2025.108126_b0210","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.drudis.2021.12.017","article-title":"Applications of density functional theory in COVID-19 drug modeling","volume":"27","author":"Ye","year":"2022","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bioorg.2025.108126_b0215","first-page":"73","article-title":"The ORCA program system","volume":"2","author":"Neese","year":"2012","journal-title":"Wiley Interdiscip. Rev."},{"key":"10.1016\/j.bioorg.2025.108126_b0220","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108126_b0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1039\/D2MD00023G","article-title":"Morpholine substituted quinazoline derivatives as anticancer agents against MCF-7, A549 and SHSY-5Y cancer cell lines and mechanistic studies","volume":"13","author":"Dwivedi","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108126_b0230","first-page":"412","article-title":"Comparison of antemortem and environmental samples for zebrafish health monitoring and quarantine","volume":"56","author":"Crim","year":"2017","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108126_b0235","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/acschemneuro.4c00007","article-title":"In vitro and in vivo investigations of chromone derivatives as potential multitarget-directed ligands: Cognitive amelioration utilizing a scopolamine-induced zebrafish model","volume":"15","author":"Kumar","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2025.108126_b0240","unstructured":"Fish, Acute Toxicity Test, OECD Guidelines for the testing of chemicals, Section 2, OECD Publishing Paris, France (2019)."},{"key":"10.1016\/j.bioorg.2025.108126_b0245","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2023.01.077","article-title":"Piperine loaded metal organic frameworks reverse doxorubicin induced chemobrain in adult zebrafish","volume":"355","author":"Arora","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.bioorg.2025.108126_b0250","doi-asserted-by":"crossref","unstructured":"O. H. Lowry, N. J. Rosebrough, A. L. Farr, R.J. Randall RJ, Protein measurement with the Folin phenol reagent, J Biol. Chem., 193 (1951) 265-275.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"10.1016\/j.bioorg.2025.108126_b0255","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanisms of lipid peroxide formation in animal tissues","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2025.108126_b0260","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/07391102.2023.2201838","article-title":"Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer\u2019s disease","volume":"42","author":"Jangid","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108126_b0265","unstructured":"Schr\u00f6dinger Release 2024-4: Maestro, Schr\u00f6dinger, LLC[software], New York, NY, 2024."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T09:10:57Z","timestamp":1740215457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"alternative-id":["S0045206825000069"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108126","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108126"}}